School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW, Australia.
Institute for Molecular Biology and Tumor Research (IMT), Philipps-University Marburg, Germany.
FEBS J. 2021 Oct;288(19):5668-5691. doi: 10.1111/febs.15837. Epub 2021 Apr 14.
Protein arginine methyltransferase 6 (PRMT6) catalyses the asymmetric dimethylation of arginines on numerous substrate proteins within the human cell. In particular, PRMT6 methylates histone H3 arginine 2 (H3R2) which affects both gene repression and activation. However, the substrate specificity of PRMT6 has not been comprehensively analysed. Here, we systematically characterise the substrate recognition motif of PRMT6, finding that it has broad specificity and recognises the RG motif. Working with a H3 tail peptide as a template, on which we made 204 amino acid substitutions, we use targeted mass spectrometry to measure their effect on PRMT6 in vitro activity. We first show that PRMT6 methylates R2 and R8 in the H3 peptide, although H3R8 is methylated with lower efficiency and is not an in vivo PRMT6 substrate. We then quantify the effect of 194 of these amino acid substitutions on methylation at both H3R2 and H3R8. In both cases, we find that PRMT6 tolerates essentially any amino acid substitution in the H3 peptide, but that positively charged and bulky residues are preferred near the target arginine. We show that PRMT6 also has preference for glycine, but only in the position immediately following the target arginine. This indicates that PRMT6 recognises the RG motif rather than the RGG motif. We further confirm this preference for the RG motif on another PRMT6 substrate, histone H4R3. This broad specificity and recognition of RG rather than RGG are distinctive among the PRMT family and has implications for the development of drugs to selectively target PRMT6. DATABASES: Panorama Public (https://panoramaweb.org/PRMT6motif.url); ProteomeXchange (PXD016711).
蛋白质精氨酸甲基转移酶 6(PRMT6)在人类细胞内的许多底物蛋白上催化精氨酸的不对称二甲基化。特别是,PRMT6 甲基化组蛋白 H3 精氨酸 2(H3R2),这既影响基因抑制又影响基因激活。然而,PRMT6 的底物特异性尚未得到全面分析。在这里,我们系统地描述了 PRMT6 的底物识别基序,发现它具有广泛的特异性,并识别 RG 基序。我们使用 H3 尾巴肽作为模板,在其上进行了 204 个氨基酸取代,然后使用靶向质谱法测量它们对 PRMT6 在体外活性的影响。我们首先表明 PRMT6 甲基化 H3 肽中的 R2 和 R8,尽管 H3R8 的甲基化效率较低,并且不是 PRMT6 的体内底物。然后,我们定量测量了 194 种这些氨基酸取代对 H3R2 和 H3R8 甲基化的影响。在这两种情况下,我们发现 PRMT6 基本上可以容忍 H3 肽中的任何氨基酸取代,但带正电荷和大体积的残基在靶精氨酸附近更受欢迎。我们表明 PRMT6 也偏爱甘氨酸,但仅在靶精氨酸后的位置。这表明 PRMT6 识别 RG 基序而不是 RGG 基序。我们还在另一个 PRMT6 底物组蛋白 H4R3 上进一步证实了对 RG 基序的这种偏好。这种广泛的特异性和对 RG 而不是 RGG 的识别是 PRMT 家族的独特特征,这对开发选择性靶向 PRMT6 的药物具有重要意义。数据库:全景公共(https://panoramaweb.org/PRMT6motif.url);蛋白质组交换(PXD016711)。